A report released last year by the nonprofit Reagan-Udall Foundation for the FDA on the Food Traceability Rule noted that many retailers, suppliers, and distributors were not even aware of the sweeping standard. It also highlighted concerns related to data usage and sharing, technology, and the complexity of the process.

The meeting, which is being facilitated by the Reagan-Udall Foundation, follows the FDA’s announcement in May that it aims to remove orally ingestible unapproved products containing fluoride that are prescribed for children from the market.

A July 10 webinar hosted by the Reagan-Udall Foundation for the Food and Drug Administration, along with the FDA, will continue the agency’s ongoing discussion of the Food Traceability Rule.

The Reagan-Udall Foundation has released a vital report titled “Transforming Animal Health in the U.S. for the 21st Century.” The expert panel behind it, chaired by Professor Lisa Tell, reviewed challenges in the U.S. animal health system and found that current laws are no longer effective.

Distinguished Professor Lisa Tell recently served as chair on a panel of experts tasked with identifying holistic approaches to address opportunities and challenges in animal health and veterinary medicine. The panel, convened by the Reagan-Udall Foundation for the Federal Drug Administration, released their report: “Transforming Animal Health In The U.S. For The 21st Century.”

The Reagan-Udall Foundation Report entitled “Transforming Animal Health in the US for the 21st Century” makes a compelling case for modernizing the work and authorities of the Center for Veterinary Medicine (CVM).

The agency’s lack of resources was documented in an assessment of the FDA’s food budget by the independent Reagan Udall Foundation. It showed shortfalls in the agency’s ability to ensure a safe food supply because of funding constraints. The assessment was done in 2022 and budget shortfalls continue, according to the recent research report.

TransCelerate BioPharma (TransCelerate), a nonprofit organization dedicated to improving the health of people around the world by accelerating and simplifying the clinical research process, today announced its participation in numerous sessions at the DIA 2025 Global Annual Meeting in Washington, D.C. from June 15–19.

In fact, according to a report by the independent Reagan-Udall Foundation, the CTP under the previous administration suffered from ineffective leadership, a lack of direction and a culture that stifles scientific integrity.

In 2024, a workshop cohosted by FDA and the Reagan-Udall Foundation for the FDA (Reagan-Udall) focusing on advancing psychedelic clinical study design. Also in 2024, a second workshop by Reagan-Udall focusing specifically on understanding potential therapeutic uses of ketamine.